Clearance to market azithromycin as prevention for a common OI in advanced AIDS.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D017963:Azithromycin